CNTB

Connect Biopharma Holdings Limited Ordinary Shares
CNTB

Overview Fund Activity

29 hedge funds and large institutions have $13M invested in Connect Biopharma Holdings Limited Ordinary Shares in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 6 closing their positions.

Holders
29
Holders Change
+1
Holders Change %
+3.57%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
9
Reduced
6
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
UOC
1
UBS O'Connor
Illinois
$567K
2
KCM
2
Kynam Capital Management
New Jersey
$643K
3
Citadel Advisors
3
Citadel Advisors
Florida
$357K
4
Citigroup
4
Citigroup
New York
$327K
5
DCM
5
DAFNA Capital Management
California
$218K

Top Sellers

1
RI
1
RTW Investments
New York
$0
2
Barclays
2
Barclays
United Kingdom
$0
3
OCA
3
Octagon Capital Advisors
New York
$0
4
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$637K
5
BlackRock
5
BlackRock
New York
$1.25M
Name Holding Trade Value Shares
Change 		Shares
Change %
Wells Fargo
26
Wells Fargo
California
$1K +$997 +997 +33,233%
RI
27
RTW Investments
New York
– -$1.35M -446,564 Closed
Barclays
28
Barclays
United Kingdom
– -$947K -313,732 Closed
OCA
29
Octagon Capital Advisors
New York
– -$845K -279,921 Closed
Invesco
30
Invesco
Georgia
– -$183K -60,449 Closed
WP
31
Woodline Partners
California
– -$132K -43,871 Closed
Simplex Trading
32
Simplex Trading
Illinois
– -$3K -1,255 Closed
1
2